Pre-Implantation
Diagnosis:
An Inevitable Quest for Human Perfection?
______________
Designer babies are becoming a reality, but at what cost?
by
Siavoche Siassi
With the rapid progress of modern-day medicine, one would be
hard-pressed to find a scientific advent that has not brought
with it a number of far-reaching implications for society as
a whole. Recent developments in the human genome project have
yielded a number of scientific procedures which only half a
century ago would have been considered outlandish. A particularly
controversial practice which has emerged is pre-implantation
diagnosis, in which normally fertile couples choose to undergo
in-vitro fertilization to screen each developing embryo for
genetic disease prior to implantation in the mother's womb.
This diagnostic process, facilitated by cutting-edge genetic
technology, has the potential of not only preventing maternal-fetal
transmissions of disease, but also allowing parents to selectively
pick and choose traits that they would like their children to
possess, such as sex and hair color.
While
I am aware that many have raised valid moral objections to extra-uterine
fertilization as a procedure interfering with natural human
reproduction, and that there are still widely conflicting views
with respect to the formal definition of human conception, I
must refrain in this paper from discussing the ethical implications
of in-vitro fertilization in and of itself. Rather, I will address
the moral validity of pre-implantation genetic diagnosis, distinguishing
between preventive medical measures and other purposes of non-essential
genetic design. While pre-implantation diagnosis that is solely
intended to prevent an otherwise unviable and sick fetus from
developing should be actively encouraged by the scientific community
and bolstered by federal funds, it should not be used as a vehicle
for parents to create what they perceive to be the perfect child.
A
rigorous examination of some of the underlying ethics of utilizing
pre-implantation genetic diagnosis entails familiarity with
its biological methodology. Traditionally, pregnant women
whose babies are at high risk of acquiring genetic diseases
grave enough to warrant termination of the pregnancy have
been offered a number of prenatal procedures in-utero to diagnose
an already implanted and maturing fetus (Flinter 1008). Pre-implantation
genetic diagnosis, by contrast, involves testing the early
embryo after in-vitro fertilization has taken place and is
often preferred by parents because it circumvents the psychological
consequences of abortion (Flinter 1009). Specifically, once
the embryo has reached day three of development (6-10 cells),
a biopsy is taken to screen for any genetic defects, and only
healthy embryos are then implanted into the mother for the
remainder of the pregnancy (Flinter 1009). Alternatively,
maternal oocytes, or eggs, can be individually screened prior
to fertilization, though this route is informative only for
maternal genes (Nagy 3). Consistent with the costs of other
newly developed technologies, the price tag for pre-implantation
diagnosis is staggering, ranging currently from $6000 - $10,500
(Flinter 1008).
'Morally justified and scientifically appropriate'
It can be argued that there are a number of circumstances
which would warrant pre-implantation genetic diagnosis in
a morally justified and scientifically appropriate manner.
For example, this procedure has been used for screening against
sex-linked disorders such as Duchenne muscular dystrophy,
fragile X syndrome, and Lesch-Nyhan syndrome (Eisenberg 570).
Single gene defects such as cystic fibrosis, and chromosomal
abnormalities such as Down's Syndrome and other trisomies
are other broad categories of disease which are commonly screened
for using pre-implantation genetic diagnosis (Flinter 1008).
Parents at high risk for transmitting such diseases to their
babies should at least be offered this procedure, leaving
the moral onus of carrying out the procedure with them. It
is understandable that rather than run the risk of having
to terminate the fetus in-utero, which many parents have ambivalent
reactions to, parents would want to screen potential embryos
in-vitro to preclude enduring the emotional pressure of abortion.
Moving 'outside medical parameters'
Given that
pre-implantation genetic diagnosis involves the manipulation
of pre-embryonic cells and the selection of favorable genetic
traits, little foresight is required to imagine the extent to
which this practice could potentially be applied outside medical
parameters. Many have argued that parents should have the right
to not only screen for certain diseases, but also selectively
choose physical characteristics based entirely on personal whim.
Such applications should be discouraged by healthcare professionals
not only because the procedure carries significant risks, but
also because the long-term sociological and biological consequences
can be profound. With respect to specific gender selection,
Savulescu and Dahl argue that most parents who would choose
to exercise such an option tend to already have other children,
and their preference for a particular sex in the unborn baby
would be "based on the gender of their already existing children"
(1879). Furthermore, they argue that because most parents would
choose a particular sex different from that of their already
existing children, the notion of sex selection reinforcing gender
biases is null (Savulescu 1880). Lastly, they disagree with
the claim that allowing sex selection to take place via pre-implantation
genetic diagnosis would result in a misallocation of healthcare
resources, arguing that if people are permitted to spend their
own money on cosmetic surgery, it is "hard to see" why people
who want to pay out of their own pocket for sex selection should
be "treated differently" (Savulescu 1880).
Unfortunately, the arguments submitted by Savulescu and Dahl
suffer from a number of unsubstantiated, implicit assumptions.
They assume that that vast majority of parents who would utilize
pre-implantation genetic diagnosis for sex selection already
have children and are merely trying to balance their families
based exclusively on gender. But what about those parents who
do not have existing children and want just a single child who
is of a particular gender? Echoing concerns that I share, Damewood
argues that allowing parents this much latitude could "threaten
the innate diversity of the human population," particularly
in societies where rampant gender biases already exist such
as in many Middle and Far Eastern cultures (3144). To address
this argument even more broadly, one might ask, should society
promote the idea that the criteria of a balanced family ought
to encompass gender? I would submit that parenthood demands
the height of selflessness, and that prerequisites for being
a parent include assuming responsibility for inevitable uncertainties
with children, accepting that they may develop to be diametrically
opposed to what was initially envisioned, and hoping that one's
children are simply born healthy.
Misuse and abuse
As to
the argument by Savulescu and Dahl that using pre-implantation
genetic diagnosis for sex selection would not result in misuse
of scarce healthcare resources, I would argue to the contrary.
While Savulescu and Dahl rightly point out that doctors
are currently practicing certain cosmetic roles which have
little to do with promoting health per se and do not exhaust
public health funds since they are privately funded, this
does not excuse adding yet another costly procedure and further
altering the traditional role of doctors (1880). More importantly,
however, pre-implantation genetic diagnosis still suffers
from a number of technological limitations, a fact which should
in and of itself serve as a reason to use it prudently. By
assuming that the methodologies and societal ramifications
of cosmetic surgery are analogous to those of pre-implantation
genetic diagnosis, Savulescu and Dahl present a patently false
claim. Aside from the fact that cosmetic surgery is performed
on individuals who choose to undergo the given procedure with
their own cognizance and that pre-implantation genetic diagnosis
involves actively altering a population's gene pool, a study
by Strom et al. of 102 pregnancies after pre-implantation
diagnosis showed that the procedure was associated with a
risk of multiple gestations, cesarean delivery, placenta previa
and unknown long-term effects (1631). When viewed through
the prism of possible pregnancy complications, it is reasonable
to conclude that pre-implantation genetic diagnosis should
be used as a last resort to prevent diseases and only diseases
from being passed on to babies.
Furthermore,
allowing pre-implantation genetic diagnosis to be used for
non-medical reasons could result in a number of unintended
societal consequences, such as the creation of a super-class
of people and the promotion of a false sense of wellness.
For example, given that the procedure is a rather costly one
at the moment, Pang argues that pre-implantation genetic diagnosis
could create a "genetically engineered over-class and a disease-prone
underclass, the higher likelihood of the former being associated
with richer people" (1078). Pang's assertion is certainly
plausible when one considers that not only is gender capable
of modification with pre-implantation genetic diagnosis, but
also hair color, height, strength, and intelligence. Moreover,
how would health insurance companies, looking to minimize
costs, view humans seeking coverage who were not genetically
screened for a multitude of diseases? Many have argued that
attitudes may be fostered that "promote discrimination against
the sick and disabled because they were not 'designed' properly
prior to birth" (Damewood 3144). Damewood expresses concern
that humans born with superior genetics could possibly have
less of an incentive to engage in long-term, healthy behavior
such as regular exercise and proper nutrition (3143). Thus,
the shield of superior genetics may have the paradoxical effect
of breeding apathy, creating a new set of public health problems.
While many would be quick to dismiss these notions as a slippery-slope
set of arguments, there is simply no question that modern
genetic technology and its potential applications warrant
such discussions given the absence of regulatory laws.
Savulescu
illustrates yet another potential societal consequence of
allowing parents to choose traits for their babies favorable
to them and their families. She argues that parents should
also have the right to undergo pre-implantation genetic diagnosis
and select traits that may not be life-threatening, but are
widely perceived to be disabilities. For example, she directly
asserts that deaf parents should be allowed to select deaf
children to order to facilitate communication and share with
their children the deaf experience (Savulescu 772). She also
suggests that dwarves should be allowed to selectively choose
dwarf babies (Savulescu 772). Should full legislative protection
regarding the utility of pre-implantation genetic diagnosis
be extended to parents, the aforementioned scenarios may very
well become realities we must confront.
Deserves our 'fullest attention'
Progress
in Western medicine has advanced with such celerity that the
field of genetics has become the source of an enormously dangerous
temptation: to use genetic knowledge to facilitate disease prevention
and treatment efforts as well as to give humans more flexibility
to select characteristic traits. Given the complexity of pre-implantation
genetic diagnosis technology and its wide array of applications
either for better or worse, extensive regulatory measures emanating
from federal and state governments ought to be central to this
discussion. It would be precocious, especially at the federal
level, for institutions such as a Department of Health and Human
Services to establish regular, diverse committees consisting
of bioethicists, sociologists, legal advisors and members of
all religious denominations to debate the issue publicly. Ultimately,
however, it will require either federal or state laws to ban
the use of pre-implantation genetic diagnosis for non-medical
reasons. Determining to what extent pre-implantation diagnosis
ought to be applied beyond the parameters of medical reasons
is an almost insurmountable task. What is quite clear, however,
is that the presence of new technology carries with it a series
of new moral and ethical considerations that deserve our fullest
attention.
Siavoche
Siassi is a junior majoring in Health Promotion and Disease
Prevention. He loves doing handy work around the house and
is a self-professed "massive news junkie."
Dahl,
Edgar; Savulescu, Julian. (2000). "Sex education and
pre-implantation diagnosis." Human Reproduction,
15 (9), 1879 - 1880 .
Damewood,
Marian. (2001). "Ethical implications of anew application
of preimplantation diagnosis." JAMA, 285, 3143-3144
.
Eisenberg,
Vered H. (1997). "Preembryo research: medical aspects
and ethical considerations." Obstetrical and Gynecological
Review, 52, 565 - 574
Flinter,
Frances A. (2001). "Preimplantation genetic diagnosis."
British Medical Journal, 322 (7293), 1008 - 1009.
Nagy,
Anne-Marie. (1998). "Scientific and ethical issues of
preimplantation diagnosis." Annals of Medicine,
30, 1-6 .
Pang,
Tikki. (2002). "The implact of genomics on global health."
American Journal of Public Health, 92 (7), 1077-1079
.
Savulescu,
Julian. (2002). "Obstetric outcomes in 102 pregnancies
after preimplantation Genetic Diagnosis." American
Journal of Obstetrics and Gynecology, 182, 1629-1632.